GO
Loading...

Medicine

More

  • FDA approves new drug for rare genetic disease Tuesday, 19 Aug 2014 | 6:00 PM ET

    Cerdelga is from Genzyme, the specialty drugmaker that introduced the first drug for Gaucher's disease 20 years ago. The oral treatment could serve as an alternative to Genzyme's best-selling drug Cerezyme, which is given intravenously. Genzyme says it will soon release pricing for its new drug.

  • UPDATE 1-GameStop CEO undergoes surgery for brain tumor Tuesday, 19 Aug 2014 | 12:05 PM ET

    Aug 19- GameStop Corp, the world's largest retailer of videogame products, said Chief Executive Paul Raines underwent an unexpected surgery last week for a small cancerous brain tumor. GameStop also said the six-week treatment period will not interfere with Raines' "continued leadership" of the company.

  • GameStop CEO treated for cancerous brain tumor Tuesday, 19 Aug 2014 | 10:24 AM ET

    NEW YORK— GameStop Corp. said Tuesday that its CEO, Paul Raines, had surgery last week to remove a cancerous brain tumor. The prognosis for a full recovery is "very good," GameStop said in a filing with the Securities and Exchange Commission.

  • GameStop CEO undergoes surgery for brain tumor Tuesday, 19 Aug 2014 | 9:52 AM ET

    Aug 19- GameStop Corp, the world's largest retailer of videogame products, said Chief Executive Paul Raines underwent an unexpected surgery last week for a small cancerous brain tumor. Raines, who will be undergoing chemotherapy, will restrict his travel during the expected six week of treatment, the company said in a regulatory filing on Tuesday.

  • The epidemic of the hemorrhagic disease, which can kill up to 90 percent of those it infects, is ravaging the three small West African states of Liberia, Sierra Leone and Guinea, and also has a toehold in Nigeria, Africa's biggest economy. Between Aug. 14-16, Liberia recorded the most new deaths, 53, followed by Sierra Leone with 17, and Guinea with 14..

  • ALS raises over $13 million since July 29th     Monday, 18 Aug 2014 | 6:25 AM ET

    CNBC's Andrew Ross Sorkin looks back on some of the best ice bucket challenge videos from last week, including from Bill Gates, saying the campaign has now hit China.

  • Aug 15- Achillion Pharmaceuticals Inc said all patients treated with its experimental hepatitis C drug showed no detectable levels of the virus four weeks after the therapy, sending its shares up 18 percent. Achievement of 100 percent cure rate confirms the competitive profile of NS5A, Wells Fargo Securities analyst Brian Abrahams wrote in a note.

  • Aug 15- Achillion Pharmaceuticals Inc said interim results from a mid-stage trial showed that all patients given its experimental hepatitis C drug showed no detectable levels of the virus four weeks after completing the therapy.

  • ALS stunned by millions of dollars     Friday, 15 Aug 2014 | 7:36 AM ET
    Guests on "The Tonight Show Starring Jimmy Fallon" participate in the 'Ice Bucket Challenge' on August 12, 2014.

    Lance Slaughter from the ALS Association, discusses the phenomenon spreading across social media to dump a bucket of ice over your head to raise awareness for ALS.

  • Aug 15- Acura Pharmaceuticals Inc said the U.S. Food and Drug Administration indicated that the company may have to conduct an additional study to determine the abuse-deterrent capability of its experimental painkiller treatment. The FDA in May said data was insufficient to support the company's claim that the drug could not be abused by snorting.

  • What is ALS?     Friday, 15 Aug 2014 | 7:32 AM ET

    CNBC's Meg Tirrell explains what ALS, or Lou Gehrig's disease is, and what is known about treating the disease.

  • Is climate change key to the spread of Ebola? Friday, 15 Aug 2014 | 5:56 AM ET
    Women washing along the Niger River near Babila, Guinea.

    Ebola outbreaks may become more frequent because of climate change, scientists warn, as the deadly disease ravages West Africa.

  • Ebola toll much higher than first thought: WHO Thursday, 14 Aug 2014 | 8:13 PM ET

    Staff with the World Health Organization battling an Ebola outbreak in West Africa see evidence the numbers of reported cases and deaths vastly underestimates the scale of the outbreak.

  • *Guinea declares health emergency over virus. CONAKRY, Aug 14- Staff with the World Health Organization battling an Ebola outbreak in West Africa see evidence the numbers of reported cases and deaths vastly underestimates the scale of the outbreak, the U.N. agency said on its website on Thursday.

  • *US orders embassy family members to leave Sierra Leone. An estimated 377 people have died in Guinea since the world's worst outbreak of Ebola began in March in remote parts of a border region near Sierra Leone and Liberia.

  • Aug 13- Amgen Inc's Kyprolis drug failed to show it could extend survival compared to standard care for patients with advanced multiple myeloma, a type of blood cancer that develops in the bone marrow. Shares of Amgen were down 2.1 percent at $124.66 in after-hours trading on Wednesday.

  • Aug 13- A Phase 3 trial of Amgen Inc's Kyprolis drug failed to show it could extend survival compared to standard care for patients with advanced multiple myeloma, a type of blood cancer that develops in the bone marrow. Shares of Amgen were down 2.3 percent at $124.41 in after-hours trading on Wednesday.

  • SAN FRANCISCO, Aug 13- Intel Corp plans to use wearable gadgets such as smart watches to monitor patients with Parkinson's disease and collect data that can be shared with researchers.

  • MONROVIA, Aug 13- A consignment of experimental Ebola drugs arrived by plane in Liberia on Wednesday to treat two doctors suffering from the virus, which has killed more than 1,000 people across four West African countries.

  • Vertex to end sales of hepatitis C drug Incivek Wednesday, 13 Aug 2014 | 2:42 PM ET

    Aug 13- Vertex Pharmaceuticals Inc is stopping U.S. sales and distribution of its Incivek hepatitis C treatment, whose use has been largely supplanted by the new Sovaldi drug from Gilead Sciences Inc.. Incivek was approved in 2011 and quickly rose to annual sales of more than $1 billion.